Clinical Trial Update: ASHBY: Accelerated Super-Hypofractionated Breast Brachytherapy [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial update for ASHBY, an accelerated super-hypofractionated breast brachytherapy study sponsored by Virginia Commonwealth Universit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Breast Cancer | Phase 2 | Status: RECRUITING